Phytolab Indústria Farmacêutica

What Phytolab Indústria Farmacêutica does

Phytolab Indústria Farmacêutica is a privately held Brazilian pharmaceutical contract manufacturer founded in 1998 and headquartered in Votuporanga, in the northwest region of São Paulo state. The company is registered under CNPJ 02.817.180/0001-24 and holds ANVISA Registration 1.05184.7 with certification under Brazil's Good Manufacturing Practices standard (BPF/Boas Práticas de Fabricação). It specializes in outsourced manufacturing of liquid-form medications and dietary supplements, offering an integrated service covering three production stages — manipulation (raw material handling), filling (envase), and packaging (embalagem) — under a single BPF-audited quality system.

The company's core offering is a B2B contract manufacturing (terceirização) service sold directly to pharmaceutical companies and to supplement and vitamin manufacturers seeking to outsource production. Its revenue model is professional-services based: clients engage Phytolab for project-specific manufacturing runs, with pricing determined by scope, volume, and specifications rather than publicly disclosed rate cards. Go-to-market is sales-led and direct, supported by a basic corporate website (phytolab.com.br) and a Facebook page; there is no evidence of paid marketing, channel partners, or digital sales infrastructure. The company is led by President Oscar Bottura, who maintains a direct communication channel with clients, employees, and suppliers as part of the company's stated commitment to quality and continuous improvement.

Phytolab serves customers across the pharmaceutical and nutraceutical verticals, addressing pain points around production cost reduction, resource optimization, regulatory compliance, and access to qualified manufacturing capacity. Its geographic footprint is described as South American, with logistics supported by Votuporanga's proximity to major Brazilian road networks. The company operates as a single legal entity with no disclosed subsidiaries, external investors, or M&A activity, and maintains no public listing. No revenue, headcount, funding, or partnership data has been disclosed, leaving scale and growth metrics as data gaps for prospective investors.

Name

Phytolab Indústria Farmacêutica

Legal name

Phytolab Indústria Farmacêutica

Website

https://phytolab.com.br

Company type

Private

Founded year

1998

Operating status

Operating

Short description

Phytolab Indústria Farmacêutica is a Brazilian ANVISA-certified (BPF) pharmaceutical contract manufacturer founded in 1998, providing outsourced manipulation, filling, and packaging services for liquid-form medications and dietary supplements to pharmaceutical and nutraceutical companies from its Votuporanga, São Paulo facility.

Ownership category

akta.pro rank

Headquarters

HQ city

Votuporanga

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Phytolab generates revenue through providing outsourced manufacturing services for liquid medications and dietary supplements, including manipulation, filling (envase), and packaging (embalagem) stages. The company operates as a contract manufacturer (terceirização) serving pharmaceutical and supplement companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Phytolab Indústria Farmacêutica is a Brazilian pharmaceutical contract manufacturer that provides outsourced production services for liquid-form medications and dietary supplements. Its offering covers three integrated production stages — manipulation, filling (envase), and packaging — performed under ANVISA-certified Good Manufacturing Practices (BPF) with qualified equipment, quality control, and direct delivery to clients.

Product overview

Phytolab is a Brazilian pharmaceutical company offering a unified manufacturing and outsourcing service for the industrialization of food supplements and medications in liquid forms. The company specializes in three integrated production stages: manipulation (raw material handling), filling (envase), and packaging, all conducted under Good Manufacturing Practices (BPF) certified by ANVISA. Founded in 1998 and headquartered in Votuporanga, São Paulo, Phytolab operates as a contract manufacturer serving clients seeking quality assurance, cost-effectiveness, and flexible partnership arrangements.

Differentiator

Problem solved

Functional benefit

Products and services

• Phytolab Pharmaceutical Manufacturing (Outsourced Liquid-Form Production) Contract manufacturing service for liquid-form medications and dietary supplements, including manipulation, filling (envase), and packaging stages, conducted under ANVISA-certified Good Manufacturing Practices (BPF). Targeted at pharmaceutical companies and supplement manufacturers seeking external production capacity.
• Terceirização Produtiva (Outsourcing of Manipulation, Filling, and Packaging) Outsourced production step services — manipulation, filling, and packaging — of pharmaceutical and nutritional products, with qualified equipment, quality control through delivery, and BPF certification. Targeted at pharmaceutical companies and supplement manufacturers seeking to outsource production activities.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves3 records

Expansion highlights2 records

Direct peers

• Prati-Donaduzzi: Brazilian pharmaceutical manufacturer with significant CDMO and generic manufacturing operations. Comparable to Phytolab as a Brazilian contract manufacturer, though larger and more diversified in dosage forms.
• Natulab: Brazilian pharmaceutical manufacturer specializing in liquid medications and supplements, headquartered in Bahia. Closely comparable to Phytolab in product focus (liquid forms) and contract manufacturing service model.
• Cristália: Brazilian pharmaceutical manufacturer and CDMO based in Itapira, SP. Operates a vertically integrated manufacturing platform for liquid and other dosage forms, serving as a direct comparison for Phytolab's contract manufacturing model in the Brazilian market.
• Laborvida: Smaller Brazilian contract manufacturer serving pharmaceutical companies with manufacturing and packaging services. Comparable to Phytolab as a regional CDMO focused on outsourced production for partner brands.
• Hipolabor: Brazilian generic pharmaceutical manufacturer with strong contract manufacturing capabilities. Comparable to Phytolab as a mid-size Brazilian pharma manufacturer offering outsourced production services for liquid and other formulations.
• Geolab: Brazilian pharmaceutical manufacturer with broad contract manufacturing services for solid, liquid, and semi-solid dosage forms. Comparable to Phytolab as a Brazilian CDMO serving both internal and partner brands.
• Medquímica Industrial: Brazilian pharmaceutical manufacturer operating a contract manufacturing business similar in scope to Phytolab, with a focus on liquids, semi-solids, and other dosage forms for partner brands.

Broad incumbents

• EMS Pharma: Brazil's largest pharmaceutical company by volume with vertically integrated manufacturing. Overlaps with Phytolab in contract manufacturing services and competes for the same Brazilian pharma outsourcing demand.
• Aché Laboratórios: Major Brazilian pharmaceutical company with substantial in-house manufacturing capacity. Comparable to Phytolab as a broader Brazilian pharma manufacturer competing for CDMO and supplement manufacturing contracts.
• Eurofarma: One of the largest Brazilian pharmaceutical companies with extensive in-house manufacturing and growing CDMO capabilities. Represents a broader incumbent that competes for the same outsourcing clients as Phytolab at greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/phytolabfarmaceutica

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phytolab Indústria Farmacêutica